Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes
Alberto Martini,Filippo Turri,Ravi Barod,Bernardo Rocco,Umberto Capitanio,Alberto Briganti,Francesco Montorsi,Alexandre Mottrie,Ben Challacombe,Brunolf W. Lagerveld,Karim Bensalah,Ronney Abaza,Ketan K. Badani,Reza Mehrazin,Maurizio Buscarini,Alessandro Larcher,Kennedy Okhawere,Oscar E. Martinez,Zine-Eddine Khene,Rai Sonpreet,Nicholas Campain,Ruben De Groote,Paolo Dell’Oglio,Nikos Grivas,Sanchia Goonewardene,Ashok Hemal,Juan Gomez Rivas
DOI: https://doi.org/10.1016/j.eururo.2021.04.003
IF: 24.267
2021-12-01
European Urology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Salvage treatment for local recurrence after prior partial nephrectomy (PN) or local tumor ablation (LTA) for kidney cancer is, as of yet, poorly investigated.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To classify the treatments and standardize the nomenclature of salvage robot-assisted renal surgery, to describe the surgical technique for each scenario, and to investigate complications, renal function, and oncologic outcomes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design, setting, and participants</h3><p>Sixty-seven patients underwent salvage robot-assisted renal surgery from October 2010 to December 2020 at nine tertiary referral centers.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Surgical procedure</h3><p>Salvage robot-assisted renal surgery classified according to treatment type as salvage robot-assisted partial or radical nephrectomy (sRAPN or sRARN) and according to previous primary treatment (PN or LTA).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Measurements</h3><p>Postoperative complications, renal function, and oncologic outcomes were assessed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results and limitations</h3><p>A total of 32 and 35 patients underwent salvage robotic surgery following PN and LTA, respectively. After prior PN, two patients underwent sRAPN, while ten underwent sRARN for a metachronous recurrence in the same kidney. No intra- or perioperative complication occurred. For local recurrence in the resection bed, six patients underwent sRAPN, while 14 underwent sRARN. For sRAPN, the intraoperative complication rate was 33%; there was no postoperative complication. For sRARN, there was no intraoperative complication and the postoperative complication rate was 7%. At 3 yr, the local recurrence-free rates were 64% and 82% for sRAPN and sRARN, respectively, while the 3-yr metastasis-free rates were 80% and 79%, respectively. At 33 mo, the median estimated glomerular filtration rates (eGFRs) were 57 and 45 ml/min/1.73 m<sup>2</sup> for sRAPN and sRARN, respectively. After prior LTA, 35 patients underwent sRAPN and no patient underwent sRARN. There was no intraoperative complication; the overall postoperative complications rate was 20%. No local recurrence occurred. The 3-yr metastasis-free rate was 90%. At 43 mo, the median eGFR was 38 ml/min/1.73 m<sup>2</sup>. The main limitations are the relatively small population and the noncomparative design of the study.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Salvage robot-assisted surgery has a safe complication profile in the hands of experienced surgeons at high-volume institutions, but the risk of local recurrence in this setting is non-negligible.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Patient summary</h3><p>Patients with local recurrence after partial nephrectomy or local tumor ablation should be aware that further treatment with robot-assisted surgery is not associated with a worrisome complication profile, but also that they are at risk of further recurrence.</p>
urology & nephrology